Literature DB >> 10218662

Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat.

M Nakashima1, M Niwa, T Iwai, T Uematsu.   

Abstract

Free radicals have been suggested to be largely involved in the genesis of ischemic brain damage, as shown in the protective effects of alpha-phenyl-N-tert-butyl nitrone (PBN), a spin trapping agent, against ischemic cerebral injury. In the present study, the effects of PBN as well as MCI-186, a newly-developed free radical scavenger, and oxypurinol, an inhibitor of xanthine oxidase, were evaluated in a rat transient middle cerebral aretery (MCA) occlusion model to clarify the possible role of free radicals in the reperfusion injury of brain. The volume of cerebral infarction, induced by 2-h occlusion and subsequent 2-h reperfusion of MCA in Fisher-344 rats, was evaluated. The administration of PBN (100 mg/kg) and MCI-186 (100 mg/kg) just before reperfusion of MCA significantly reduced the infarction volume. In contrast, oxypurinol (100 mg/kg) failed to show any preventive effect on the infarction. These results suggest that free radical formation is involved in the cerebral damage induced by ischemia-reperfusion of MCA, and that hydroxyl radical is responsible for the reperfusion injury after transient focal brain ischemia. It is also suggested that xanthine oxidase is not a major source of free radicals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218662     DOI: 10.1016/s0891-5849(98)00257-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  12 in total

1.  Pro and antioxidant responses to repeated administration of diazepam in rat brain.

Authors:  S Musavi; P Kakkar
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

Review 3.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 4.  Docosahexaenoic acid accumulation in the prenatal brain: prooxidant and antioxidant features.

Authors:  E Yavin; S Glozman; P Green
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

Review 5.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

6.  Neuroprotective effect of Spirulina in cerebral ischemia-reperfusion injury in rats.

Authors:  Santhrani Thaakur; Ravi Sravanthi
Journal:  J Neural Transm (Vienna)       Date:  2010-08-11       Impact factor: 3.575

Review 7.  A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?

Authors:  Paul A Lapchak
Journal:  Expert Opin Pharmacother       Date:  2010-07       Impact factor: 3.889

Review 8.  Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.

Authors:  Paul A Lapchak
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

9.  Protective Effects of Quercetin on Rat Pial Microvascular Changes during Transient Bilateral Common Carotid Artery Occlusion and Reperfusion.

Authors:  Dominga Lapi; S Vagnani; G Pignataro; E Esposito; M Paterni; Antonio Colantuoni
Journal:  Front Physiol       Date:  2012-03-01       Impact factor: 4.566

10.  Associations of dietary iron intake with mortality from cardiovascular disease: the JACC study.

Authors:  Wen Zhang; Hiroyasu Iso; Tetsuya Ohira; Ohira Chigusa Date; Naohito Tanabe; Shogo Kikuchi; Akiko Tamakoshi
Journal:  J Epidemiol       Date:  2012-09-15       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.